- Home
- GCV vs VNRX Comparison
GCV vs VNRX Comparison
Compare GCV & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCV
- VNRX
- Stock Information
- Founded
- GCV 1988
- VNRX N/A
- Country
- GCV United States
- VNRX United States
- Employees
- GCV N/A
- VNRX N/A
- Industry
- GCV Finance/Investors Services
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GCV Finance
- VNRX Health Care
- Exchange
- GCV Nasdaq
- VNRX Nasdaq
- Market Cap
- GCV 79.7M
- VNRX 64.8M
- IPO Year
- GCV N/A
- VNRX N/A
- Fundamental
- Price
- GCV $4.10
- VNRX $0.64
- Analyst Decision
- GCV
- VNRX Strong Buy
- Analyst Count
- GCV 0
- VNRX 4
- Target Price
- GCV N/A
- VNRX $3.50
- AVG Volume (30 Days)
- GCV 57.9K
- VNRX 200.3K
- Earning Date
- GCV 01-01-0001
- VNRX 11-13-2025
- Dividend Yield
- GCV 13.04%
- VNRX N/A
- EPS Growth
- GCV N/A
- VNRX N/A
- EPS
- GCV N/A
- VNRX N/A
- Revenue
- GCV N/A
- VNRX $1,319,252.00
- Revenue This Year
- GCV N/A
- VNRX $274.46
- Revenue Next Year
- GCV N/A
- VNRX $212.60
- P/E Ratio
- GCV N/A
- VNRX N/A
- Revenue Growth
- GCV N/A
- VNRX 35.10
- 52 Week Low
- GCV $3.15
- VNRX $0.40
- 52 Week High
- GCV $4.58
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- GCV 54.17
- VNRX 47.97
- Support Level
- GCV $4.00
- VNRX $0.57
- Resistance Level
- GCV $4.28
- VNRX $0.73
- Average True Range (ATR)
- GCV 0.04
- VNRX 0.05
- MACD
- GCV 0.00
- VNRX -0.00
- Stochastic Oscillator
- GCV 33.93
- VNRX 43.75
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.